Frequency of the HIV-protective CC chemokine receptor 5-Δ32/Δ32 genotype is increased in hepatitis C

Gastroenterology

Volumn 122, Issue 7, 2002, Pages 1721-1728

  Woitas, Rainer P ^a   Ahlenstiel, Golo ^a   Iwan, Agathe ^a   Rockstroh, Jürgen K ^a   Brackmann, Hans H ^a   Kupfer, Bernd ^a   Matz, Bertfried ^a   Offergeld, Ruth ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR1;

ADULT; AGED; ARTICLE; BASE PAIRING; CELL PROTECTION; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS LOAD;

EID: 0036083009     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.33660     Document Type: Article

References (29)

1. + cells is mediated by the chemokine receptor CC-CKR-5
2. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
3. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
4. Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor
5. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5
6. Phenotypic expressions of CCR5-delta32/delta32 homozygosity
7. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence
8. German-Austrian guidelines for antiretroviral therapy of HIV infection. 1997. Common statement of the Deutsche AIDS-Gesellschaft (DAIG) and Osterreichische AIDS-Gesellschaft (OAG)
9. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
10. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection
11. CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes
12. An immunoassay for specific amplified HCV sequences
13. Introduction in statistical methods
14. Protection against parenteral HIV-1 infection by homozygous deletion in the C-C chemokine receptor 5 gene
15. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C
16. C-C chemokines, pivotal in protection against HIV type 1 infection
17. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-lbeta, and MIP-1alpha
18. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
19. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
20. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
21. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
22. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
23. CCR5 is characteristic of Th1 lymphocytes
24. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
25. Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood
26. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection
27. Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C
28. + lymphocyte-associated Th2-type immune response in the intestine
29. SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo